Have questions about SeaStar Medical’s Selective Cytopheretic Device (SCD)? Interested in SCD clinical trials? Want to become an investor or partner with a company that is passionate about advancing the critical-care paradigm and has the product to do it? Then reach out to us at info@seastarmed.com and we will be in touch.
SeaStar Medical is a medical technology company that is redefining how extracorporeal therapies may reduce the consequences of excessive inflammation on vital organs. SeaStar Medical’s novel technologies provide life-saving solutions to critically ill patients. We are developing and commercializing cell-directed extracorporeal therapies that target the key immune cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
©SeaStar Medical 2023